CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. FFAI
9. TRMD
10. ACN

Go back to CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
(NASDAQ: CGON) Delayed: 74.62 -1 (1.32%)
Previous Close $75.62    52 Week High $ 
Open $75.87    52 Week Low $ 
Day High $75.87    P/E N/A 
Day Low $72.82    EPS $ 
Volume 1,779,246